Overview

Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP)

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate effect of candesartan based therapy on percent change of B type natriuretic peptides(BNP) level in the subjects with hypertension and left ventricular hypertrophy.
Phase:
Phase 4
Details
Lead Sponsor:
AstraZeneca
Treatments:
Candesartan
Candesartan cilexetil
Felodipine
Natriuretic Peptide, Brain